Roche introduces cobas Respiratory Flex test, utilizing TAGS technology to simultaneously detect up to 12 respiratory viruses, including Influenza A and SARS-CoV-2.

Roche has introduced the cobas Respiratory Flex test, the first to utilize its TAGS technology, allowing simultaneous detection of up to 12 respiratory viruses in one PCR test. This innovation expands pathogen identification from four to fifteen, enabling efficient syndromic testing on cobas 5800, 6800, and 8800 analyzers. The test can identify common viruses such as Influenza A and SARS-CoV-2, marking a significant advancement in infectious disease testing.

September 24, 2024
7 Articles